US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alzamend Neuro, Inc

2.25

-0.2700-10.71%

Post-market: 2.270.0199+0.88%19:57 EDT

Volume:306.21K

Turnover:709.30K

Market Cap:6.52M

PE:-0.16

High:2.45

Open:2.39

Low:2.20

Close:2.52

Loading ...

Overview Company News Filings

Director Sells Thousands of Alzamend Neuro Shares!

Director and 10% Owner Milton C. Ault III Reports Disposal of Common Shares of Alzamend Neuro Inc

Alzamend Neuro to Present at the 2025 Military Health System Research Symposium

Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs

Alzamend Neuro Inc. Reports No Revenue, Net Loss Narrows by 49.9%, EPS Improves by $121.27

Alzamend Neuro Inc. Eliminates Series A Preferred Stock in Bylaw Amendment

Press Release: Alzamend Neuro Announces Final Closing of $5 Million Private Placement Months Ahead of Schedule

Crude Oil Falls Over 1%; Best Buy Reports Downbeat Results

Alzamend Neuro Stock (ALZN) Rockets 145% on Study Update

BRIEF-Alzamend Neuro Announces Dosing Of First Patient In Phase II Clinical Trial Of Al001 “Lithium In Brain” Study

BRIEF-Alzamend Neuro Enrolls First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study

Milton C. Ault III, Director and 10% Owner, Reports Disposal of Alzamend Neuro Inc. Common Shares

Is Alzamend Neuro, Inc. (ALZN) the Cheapest Stock Insiders Are Buying In March?

Alzamend Neuro announces initiation date of Phase II trial of AL001

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Alzheimer’s Disease to take Place at Massachusetts General Hospital

Alzamend Neuro announces initiation of Phase II trial of AL001

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital

BRIEF-Alzamend Neuro Announces Initiation Date Of Phase II Clinical Trial Of AL001 For Treatment Of Bipolar Disorder To Take Place At Massachusetts General Hospital

Alzamend Neuro announces initiation date of Phase II trial of AL001

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALZN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALZN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALZN\",,,,,undefined,":{"symbol":"ALZN","market":"US","secType":"STK","nameCN":"Alzamend Neuro, Inc","latestPrice":2.25,"timestamp":1753992000000,"preClose":2.52,"halted":0,"volume":306208,"hourTrading":{"tag":"盘后","latestPrice":2.2699,"preClose":2.25,"latestTime":"19:57 EDT","volume":4789,"amount":10782.5499,"timestamp":1754006277119},"delay":0,"floatShares":2879300,"shares":2896432,"eps":-14.470992,"marketStatus":"Closed","change":-0.27,"latestTime":"07-31 16:00:00 EDT","open":2.39,"high":2.4499,"low":2.2,"amount":709303.579488,"amplitude":0.099167,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-14.470992,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754035200000},"marketStatusCode":5,"adr":0,"listingDate":1623729600000,"exchange":"NASDAQ","adjPreClose":2.52,"preHourTrading":{"tag":"盘前","latestPrice":2.4,"preClose":2.52,"latestTime":"09:27 EDT","volume":8759,"amount":21501.663271999998,"timestamp":1753968434949},"postHourTrading":{"tag":"盘后","latestPrice":2.2699,"preClose":2.25,"latestTime":"19:57 EDT","volume":4789,"amount":10782.5499,"timestamp":1754006277119},"volumeRatio":1.254209,"impliedVol":1.3738,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALZN\",,,,,undefined,":{"symbol":"ALZN","floatShares":2879300,"roa":"-107.38%","roe":"-657.17%","lyrEps":-132.329799,"volumeRatio":1.254209,"shares":2896432,"dividePrice":0,"high":2.4499,"amplitude":0.099167,"preClose":2.52,"low":2.2,"week52Low":2.2,"pbRate":"1.64","week52High":135.54,"institutionHeld":0,"latestPrice":2.25,"eps":-14.470992,"divideRate":0,"volume":306208,"delay":0,"ttmEps":-14.470992,"open":2.39,"prevYearClose":10.44,"prevWeekClose":2.96,"prevMonthClose":2.91,"prevQuarterClose":2.91,"fiveDayClose":2.99,"twentyDayClose":3,"sixtyDayClose":6.12},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALZN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2555095260","title":"Director Sells Thousands of Alzamend Neuro Shares!","url":"https://stock-news.laohu8.com/highlight/detail?id=2555095260","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555095260?lang=en_us&edition=fundamental","pubTime":"2025-07-30 10:08","pubTimestamp":1753841317,"startTime":"0","endTime":"0","summary":"New insider activity at Alzamend Neuro ( ($ALZN) ) has taken place on July 29, 2025. Director Milton C III Ault recently sold 44,843 shares of Alza...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/director-sells-thousands-of-alzamend-neuro-shares-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/director-sells-thousands-of-alzamend-neuro-shares-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","ALZN","BK4139"],"gpt_icon":0},{"id":"2555061105","title":"Director and 10% Owner Milton C. Ault III Reports Disposal of Common Shares of Alzamend Neuro Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2555061105","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555061105?lang=en_us&edition=fundamental","pubTime":"2025-07-30 04:56","pubTimestamp":1753822574,"startTime":"0","endTime":"0","summary":"Milton C. Ault III, a director and 10% owner of Alzamend Neuro, Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alzamend Neuro Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 29, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250729:nNDL6k520P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","ALZN"],"gpt_icon":0},{"id":"2554779242","title":"Alzamend Neuro to Present at the 2025 Military Health System Research Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2554779242","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554779242?lang=en_us&edition=fundamental","pubTime":"2025-07-28 20:00","pubTimestamp":1753704000,"startTime":"0","endTime":"0","summary":"Session Topic is the Innovation and Current Directions in Military Suicide Prevention, Research, and ProgramsPresentation Title is Quantitate Differences in Lithium Brain-to-Plasma Exposure in PTSD Su","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/28/3122431/0/en/Alzamend-Neuro-to-Present-at-the-2025-Military-Health-System-Research-Symposium.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVC","BK4539","BK4139","ALZN"],"gpt_icon":0},{"id":"2553248885","title":"Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2553248885","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553248885?lang=en_us&edition=fundamental","pubTime":"2025-07-23 20:00","pubTimestamp":1753272000,"startTime":"0","endTime":"0","summary":"During the year ended April 30, 2025, net cash provided by financing activities was $10.4 millionStockholder equity of $4.0 million at April 30, 2025, including $3.9 million of cashIn May 2025, Alzame","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/23/3120190/0/en/Alzamend-Neuro-Reports-Annual-2025-Financial-Results-and-Provides-Update-on-Clinical-Programs.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALZN","ABVC"],"gpt_icon":0},{"id":"2553265138","title":"Alzamend Neuro Inc. Reports No Revenue, Net Loss Narrows by 49.9%, EPS Improves by $121.27","url":"https://stock-news.laohu8.com/highlight/detail?id=2553265138","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553265138?lang=en_us&edition=fundamental","pubTime":"2025-07-23 04:31","pubTimestamp":1753216297,"startTime":"0","endTime":"0","summary":"Alzamend Neuro Inc. released its financial results for the fiscal year ending April 30, 2025. The company reported a net loss attributable to common shares of approximately $4.99 million, a decrease from the previous year's net loss of about $9.95 million, reflecting a 49.9% improvement. Total operating expenses were $4.50 million, down 55% from $9.94 million the prior year. Research and development expenses significantly decreased by 78% to $1.41 million from $6.46 million, while general and administrative expenses also saw a reduction of 12% to $3.08 million from $3.48 million. The company's product candidates, AL001 and ALZN002, remain in the clinical stage of development, requiring further study, evaluation, and regulatory approval before generating revenue. Alzamend Neuro Inc. continues to advance the clinical development of AL001 for the treatment of Alzheimer's, BD, MDD, and PTSD, as well as ALZN002 for Alzheimer's treatment. The company is also focused on expanding its pipeline","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250722:nNDL99Q9dl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALZN"],"gpt_icon":0},{"id":"2550663971","title":"Alzamend Neuro Inc. Eliminates Series A Preferred Stock in Bylaw Amendment","url":"https://stock-news.laohu8.com/highlight/detail?id=2550663971","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550663971?lang=en_us&edition=fundamental","pubTime":"2025-07-10 04:31","pubTimestamp":1752093076,"startTime":"0","endTime":"0","summary":"Alzamend Neuro Inc. announced an amendment to its bylaws with the filing of a Certificate of Elimination for its Series A convertible preferred stock. This filing effectively removes all matters related to the Series A Preferred Stock from the company's Certificate of Incorporation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alzamend Neuro Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nNDL82XpxB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ALZN","BK4139"],"gpt_icon":0},{"id":"2543672852","title":"Press Release: Alzamend Neuro Announces Final Closing of $5 Million Private Placement Months Ahead of Schedule","url":"https://stock-news.laohu8.com/highlight/detail?id=2543672852","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543672852?lang=en_us&edition=fundamental","pubTime":"2025-06-16 20:00","pubTimestamp":1750075200,"startTime":"0","endTime":"0","summary":"ATLANTA, June 16, 2025  -- Alzamend Neuro, Inc.  , a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease , bipolar disorder , major depressive disorder  and post-traumatic stress disorder , today announced that it has completed the final closing of its $5 million private placement.On Friday, June 13, 2025, the Investor purchased the remaining available shares of Preferred Stock in the Financing, months ahead of the originally scheduled final Tranche Closing in October 2025. With $5 million in gross proceeds from this Financing received, Alzamend's financial position is significantly increased, and Alzamend would receive additional proceeds should the Investor exercise the Warrants.Alzamend Neuro is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's, BD, MDD and PTSD. Our mission is to rapidly develop and market safe and effective treatments. Our current pipel","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALZN","BK4139","ABVC"],"gpt_icon":0},{"id":"2539267446","title":"Crude Oil Falls Over 1%; Best Buy Reports Downbeat Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2539267446","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539267446?lang=en_us&edition=fundamental","pubTime":"2025-05-30 01:13","pubTimestamp":1748538822,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45677149/crude-oil-falls-over-1-best-buy-reports-downbeat-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","LU0868494708.USD","ORIC","LU0942090050.USD","PSQ","BK4588","BK4076","BBY","ALZN","STRM","QID","USAW.SI","MNQmain","NQmain","BK4167","CAL","IE00B7SZL793.SGD","TSYW.SI","BK4585","EOSE","NVIW.SI","BK4139","SQQQ","QLD","BK4094","USJW.SI","REVB","BK4539",".IXIC","BK4096","BK4533","IE00B19Z4B17.USD","IE0031619046.USD","LU0868494617.USD","IE00B66KJ199.SGD","TQQQ"],"gpt_icon":1},{"id":"2539602265","title":"Alzamend Neuro Stock (ALZN) Rockets 145% on Study Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2539602265","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539602265?lang=en_us&edition=fundamental","pubTime":"2025-05-29 21:25","pubTimestamp":1748525140,"startTime":"0","endTime":"0","summary":"Alzamend Neuro stock rocketed on Thursday after the company announced an update to a Phase II clinical study of AL001.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/alzamend-neuro-stock-alzn-rockets-145-on-study-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/alzamend-neuro-stock-alzn-rockets-145-on-study-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","ALZN","BK4139"],"gpt_icon":0},{"id":"2539250267","title":"BRIEF-Alzamend Neuro Announces Dosing Of First Patient In Phase II Clinical Trial Of Al001 “Lithium In Brain” Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2539250267","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539250267?lang=en_us&edition=fundamental","pubTime":"2025-05-29 20:27","pubTimestamp":1748521665,"startTime":"0","endTime":"0","summary":"BRIEF-Alzamend Neuro Announces Dosing Of First Patient In Phase II Clinical Trial Of Al001 “Lithium In Brain” Study May 29 (Reuters) - Alzamend Neuro Inc ALZN.O:ALZAMEND NEURO ANNOUNCES DOSING OF FIRS","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nTUA8T0MFT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALZN","BK4539"],"gpt_icon":0},{"id":"2536681397","title":"BRIEF-Alzamend Neuro Enrolls First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2536681397","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536681397?lang=en_us&edition=fundamental","pubTime":"2025-05-19 20:18","pubTimestamp":1747657104,"startTime":"0","endTime":"0","summary":"BRIEF-Alzamend Neuro Enrolls First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” StudyMay 19 (Reuters) - Alzamend Neuro Inc ALZN.O:ALZAMEND NEURO ENROLLS FIRST PATIENT IN ITS PHAS","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nTUA8PYZLQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALZN","BK4539"],"gpt_icon":0},{"id":"2535888794","title":"Milton C. Ault III, Director and 10% Owner, Reports Disposal of Alzamend Neuro Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2535888794","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535888794?lang=en_us&edition=fundamental","pubTime":"2025-05-15 05:00","pubTimestamp":1747256442,"startTime":"0","endTime":"0","summary":"Milton C. Ault III, a Director and 10% Owner of Alzamend Neuro Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alzamend Neuro Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL3W047v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","ALZN"],"gpt_icon":0},{"id":"2522501881","title":"Is Alzamend Neuro, Inc. (ALZN) the Cheapest Stock Insiders Are Buying In March?","url":"https://stock-news.laohu8.com/highlight/detail?id=2522501881","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522501881?lang=en_us&edition=fundamental","pubTime":"2025-03-28 22:42","pubTimestamp":1743172945,"startTime":"0","endTime":"0","summary":"We recently published a list of 15 Cheapest Stocks Insiders Are Buying In March. In this article, we are going to take a look at where Alzamend Neuro, Inc.  stands against other cheapest stocks insiders are buying in March.After solid gains Monday, the broader market index and blue chip companies traded flat Tuesday, while the NASDAQ Composite rose 0.2%. Monday’s enthusiasm came from hopes of looser U.S. tariffs.Investors mostly ignored the March consumer confidence data released on Tuesday, which showed a sharp decline in U.S. consumers’ short-term outlook on income, business, and job conditions, reports CNBC.“Sentiment continues to wane among investors, consumers and businesses as economic concerns and economic policy uncertainty takes its toll,” said Bret Kenwell, U.S. investment analyst at eToro. “Until there’s more certainty on the tariff and macro front, sentiment and confidence remain vulnerable.”What are some of the cheapest stocks insiders have been buying this month so far?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alzamend-neuro-inc-alzn-cheapest-144225546.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":[".IXIC","BK4139","BK4539","SQQQ","MNQmain","NQmain","QLD","COMP","TQQQ","TSYW.SI","USJW.SI","USAW.SI","NVIW.SI","QID","ALZN","PSQ"],"gpt_icon":1},{"id":"2522889073","title":"Alzamend Neuro announces initiation date of Phase II trial of AL001","url":"https://stock-news.laohu8.com/highlight/detail?id=2522889073","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522889073?lang=en_us&edition=fundamental","pubTime":"2025-03-26 02:40","pubTimestamp":1742928014,"startTime":"0","endTime":"0","summary":"Alzamend Neuro (ALZN) announced its plans to initiate a highly anticipated phase II clinical study of AL001 for treatment of patients with Alzheime...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alzamend-neuro-announces-initiation-date-of-phase-ii-trial-of-al001-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alzamend-neuro-announces-initiation-date-of-phase-ii-trial-of-al001-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","ALZN"],"gpt_icon":0},{"id":"2522222760","title":"Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Alzheimer’s Disease to take Place at Massachusetts General Hospital","url":"https://stock-news.laohu8.com/highlight/detail?id=2522222760","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522222760?lang=en_us&edition=fundamental","pubTime":"2025-03-25 20:00","pubTimestamp":1742904000,"startTime":"0","endTime":"0","summary":"Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure pharmacokinetics in Alzheimer’s subjectsATLANTA, ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/25/3048659/0/en/Alzamend-Neuro-Announces-Initiation-Date-of-Phase-II-Clinical-Trial-of-AL001-for-Treatment-of-Alzheimer-s-Disease-to-take-Place-at-Massachusetts-General-Hospital.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALZN"],"gpt_icon":0},{"id":"2518745256","title":"Alzamend Neuro announces initiation of Phase II trial of AL001","url":"https://stock-news.laohu8.com/highlight/detail?id=2518745256","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518745256?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:21","pubTimestamp":1741695715,"startTime":"0","endTime":"0","summary":"Alzamend Neuro (ALZN) announced its plans to initiate a highly anticipated phase II clinical study of AL001 for treatment of patients with PTSD in ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alzamend-neuro-announces-initiation-of-phase-ii-trial-of-al001?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alzamend-neuro-announces-initiation-of-phase-ii-trial-of-al001?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","ALZN"],"gpt_icon":0},{"id":"2518226748","title":"Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital","url":"https://stock-news.laohu8.com/highlight/detail?id=2518226748","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518226748?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:00","pubTimestamp":1741694400,"startTime":"0","endTime":"0","summary":"Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure pharmacokinetics in PTSD subjects. Approximately 1 in 13 people in the US will develop PTSD in their lifetime. All rights reserved; proprietary content owned by Alzamend Neuro, Inc.Many people with PTSD need professional treatment to recover from psychological distress. The earlier a person gets treatment, the better the chance of recovery. Alzamend Neuro is committed to the treatments and cures of Post-Traumatic Stress Disorder . All rights reserved; proprietary content owned by Alzamend Neuro, Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/11/3040512/0/en/Alzamend-Neuro-Announces-Initiation-Date-of-Phase-II-Clinical-Trial-of-AL001-for-Treatment-of-Post-Traumatic-Stress-Disorder-to-take-Place-at-Massachusetts-General-Hospital.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POST","ALZN","BK4212","BK4139","BK4539"],"gpt_icon":0},{"id":"2516674118","title":"BRIEF-Alzamend Neuro Announces Initiation Date Of Phase II Clinical Trial Of AL001 For Treatment Of Bipolar Disorder To Take Place At Massachusetts General Hospital","url":"https://stock-news.laohu8.com/highlight/detail?id=2516674118","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516674118?lang=en_us&edition=fundamental","pubTime":"2025-03-04 22:14","pubTimestamp":1741097671,"startTime":"0","endTime":"0","summary":"BRIEF-Alzamend Neuro Announces Initiation Date Of Phase II Clinical Trial Of AL001 For Treatment Of Bipolar Disorder To Take Place At Massachusetts General HospitalMarch 4 (Reuters) - Alzamend Neuro I","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUA9W1GY0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ALZN","BK4139"],"gpt_icon":0},{"id":"2516567154","title":"Alzamend Neuro announces initiation date of Phase II trial of AL001","url":"https://stock-news.laohu8.com/highlight/detail?id=2516567154","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516567154?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:31","pubTimestamp":1741095092,"startTime":"0","endTime":"0","summary":"Alzamend Neuro (ALZN) announced its plans to initiate a highly anticipated phase II clinical study of AL001 for treatment of patients with BD, whic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alzamend-neuro-announces-initiation-date-of-phase-ii-trial-of-al001?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alzamend-neuro-announces-initiation-date-of-phase-ii-trial-of-al001?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","ALZN"],"gpt_icon":0},{"id":"2516761266","title":"Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital","url":"https://stock-news.laohu8.com/highlight/detail?id=2516761266","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516761266?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:10","pubTimestamp":1741093800,"startTime":"0","endTime":"0","summary":"Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure pharmacokinetics in Bipolar Disorder subjects. Over 7 Million Americans are projected to be living with Bipolar Disorder.Bipolar disorder  is a medical condition that causes dramatic shifts in a person's mood, energy, and ability to think clearly.@2025 all rights reserved, property of Alzamend Neuro, Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/04/3036492/0/en/Alzamend-Neuro-Announces-Initiation-Date-of-Phase-II-Clinical-Trial-of-AL001-for-Treatment-of-Bipolar-Disorder-to-take-Place-at-Massachusetts-General-Hospital.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","ALZN"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":28,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALZN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-07-22","symbol":"ALZN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1753156800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-05-12","symbol":"ALZN","defaultRemindTime":1747056600000,"type":"split","dateTimestamp":1747022400000,"forFactor":9,"toFactor":1,"ratio":9},{"market":"US","date":"2025-03-10","symbol":"ALZN","fiscalQuarterEnding":"2025/01","expectedEps":-0.29,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741579200000,"reportTimeType":"post","actualEps":-0.19},{"market":"US","date":"2024-12-11","symbol":"ALZN","fiscalQuarterEnding":"2024/10","expectedEps":-2.38,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1733893200000,"reportTimeType":"post","actualEps":-0.4},{"market":"US","date":"2024-09-11","symbol":"ALZN","fiscalQuarterEnding":"2024/07","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1726027200000,"reportTimeType":"post","actualEps":-1.25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALZN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALZN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1740542400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALZN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALZN","date":"2025-07-30","current":-1.667989,"percent":0.552964,"low":-227.195707,"twenty":-10.26314,"median":-3.068129,"eighty":-0.523744,"high":-0.165749,"avg":-11.469198,"sd":24.590531,"marketCap":7530723},"quantilePoints":[{"date":"2021-06-11","current":-64.165808,"twenty":-64.165808,"median":-64.165808,"eighty":-64.165808,"marketCap":323814290},{"date":"2021-06-18","current":-151.968684,"twenty":-174.183375,"median":-160.888219,"eighty":-84.146558,"marketCap":766913610},{"date":"2021-06-25","current":-144.73208,"twenty":-169.807754,"median":-144.73208,"eighty":-136.65401,"marketCap":730393915},{"date":"2021-07-02","current":-122.517389,"twenty":-169.807754,"median":-145.910131,"eighty":-129.249113,"marketCap":618286942},{"date":"2021-07-09","current":-103.16368,"twenty":-163.210664,"median":-140.188166,"eighty":-108.650035,"marketCap":520617988},{"date":"2021-07-16","current":-103.836853,"twenty":-153.887226,"median":-129.249113,"eighty":-104.240756,"marketCap":524015169},{"date":"2021-07-23","current":-96.431956,"twenty":-150.756974,"median":-117.384448,"eighty":-96.56659,"marketCap":486646178},{"date":"2021-07-30","current":-74.797882,"twenty":-147.761356,"median":-107.875887,"eighty":-88.25291,"marketCap":377472523},{"date":"2021-08-06","current":-71.417558,"twenty":-145.203301,"median":-104.089292,"eighty":-78.127867,"marketCap":360413489},{"date":"2021-08-13","current":-59.743534,"twenty":-142.03939,"median":-102.827094,"eighty":-74.045435,"marketCap":301499745},{"date":"2021-08-20","current":-55.62329,"twenty":-139.481335,"median":-94.749024,"eighty":-69.872466,"marketCap":280706659},{"date":"2021-08-27","current":-49.614601,"twenty":-137.125231,"median":-88.353886,"eighty":-63.350024,"marketCap":250383409},{"date":"2021-09-03","current":-53.734845,"twenty":-130.730092,"median":-83.389239,"eighty":-57.202717,"marketCap":271176495},{"date":"2021-09-10","current":-50.644662,"twenty":-125.210079,"median":-77.164368,"eighty":-56.481674,"marketCap":255581681},{"date":"2021-09-17","current":-37.342199,"twenty":-119.488113,"median":-74.679417,"eighty":-53.391491,"marketCap":225908430},{"date":"2021-09-24","current":-34.469722,"twenty":-117.367619,"median":-72.566282,"eighty":-51.777729,"marketCap":208530859},{"date":"2021-10-01","current":-41.363667,"twenty":-112.554436,"median":-69.872466,"eighty":-50.232638,"marketCap":250237031},{"date":"2021-10-08","current":-36.62408,"twenty":-108.481742,"median":-67.554829,"eighty":-40.789171,"marketCap":221564037},{"date":"2021-10-15","current":-34.326098,"twenty":-106.563201,"median":-60.086887,"eighty":-38.002869,"marketCap":207661980},{"date":"2021-10-22","current":-30.304631,"twenty":-104.88027,"median":-57.425897,"eighty":-37.514548,"marketCap":183333380},{"date":"2021-10-29","current":-30.735502,"twenty":-104.038805,"median":-56.653351,"eighty":-35.561263,"marketCap":185940016},{"date":"2021-11-05","current":-41.363667,"twenty":-103.432949,"median":-56.052482,"eighty":-34.843144,"marketCap":250237031},{"date":"2021-11-12","current":-33.607979,"twenty":-102.961728,"median":-53.734845,"eighty":-34.469722,"marketCap":203317587},{"date":"2021-11-19","current":-31.166374,"twenty":-99.090987,"median":-52.447268,"eighty":-33.780328,"marketCap":188546651},{"date":"2021-11-26","current":-32.602612,"twenty":-96.532932,"median":-51.760562,"eighty":-33.177108,"marketCap":197235437},{"date":"2021-12-03","current":-28.437521,"twenty":-95.085611,"median":-51.331369,"eighty":-32.660062,"marketCap":172037958},{"date":"2021-12-10","current":-31.597245,"twenty":-91.315845,"median":-46.925373,"eighty":-32.516438,"marketCap":191153287},{"date":"2021-12-17","current":-26.241096,"twenty":-88.555838,"median":-41.363667,"eighty":-31.884493,"marketCap":217683377},{"date":"2021-12-23","current":-23.0279,"twenty":-88.25291,"median":-39.927428,"eighty":-31.597245,"marketCap":191028269},{"date":"2021-12-31","current":-20.350237,"twenty":-87.108517,"median":-38.13213,"eighty":-30.936576,"marketCap":168815680},{"date":"2022-01-07","current":-20.56445,"twenty":-83.84363,"median":-37.916695,"eighty":-30.735502,"marketCap":170592687},{"date":"2022-01-14","current":-19.172066,"twenty":-81.859576,"median":-37.701259,"eighty":-30.362081,"marketCap":159042140},{"date":"2022-01-21","current":-16.28019,"twenty":-78.770199,"median":-37.414011,"eighty":-29.012016,"marketCap":135052544},{"date":"2022-01-28","current":-15.423338,"twenty":-75.558538,"median":-35.618713,"eighty":-27.740587,"marketCap":127944515},{"date":"2022-02-04","current":-14.566486,"twenty":-74.797882,"median":-35.475089,"eighty":-25.705563,"marketCap":120836486},{"date":"2022-02-11","current":-14.994912,"twenty":-74.679417,"median":-34.75697,"eighty":-23.0279,"marketCap":124390501},{"date":"2022-02-18","current":-13.709634,"twenty":-74.385557,"median":-34.39791,"eighty":-21.528409,"marketCap":113728458},{"date":"2022-02-25","current":-12.317249,"twenty":-73.025069,"median":-34.038851,"eighty":-20.950034,"marketCap":102177911},{"date":"2022-03-04","current":-12.317249,"twenty":-72.495084,"median":-33.607979,"eighty":-20.264552,"marketCap":102177911},{"date":"2022-03-11","current":-10.282225,"twenty":-71.62357,"median":-32.939333,"eighty":-18.893589,"marketCap":85296343},{"date":"2022-03-18","current":-10.443205,"twenty":-70.181484,"median":-32.88986,"eighty":-16.644352,"marketCap":101815963},{"date":"2022-03-25","current":-11.367382,"twenty":-69.872466,"median":-32.674424,"eighty":-16.087398,"marketCap":110826226},{"date":"2022-04-01","current":-10.720458,"twenty":-69.460442,"median":-32.602612,"eighty":-15.401917,"marketCap":104519042},{"date":"2022-04-08","current":-10.350787,"twenty":-66.473265,"median":-31.884493,"eighty":-14.887805,"marketCap":100914937},{"date":"2022-04-14","current":-9.611445,"twenty":-64.800374,"median":-31.740869,"eighty":-14.780699,"marketCap":93706727},{"date":"2022-04-22","current":-8.354564,"twenty":-61.718455,"median":-31.597245,"eighty":-14.030953,"marketCap":81452771},{"date":"2022-04-29","current":-9.731754,"twenty":-59.880875,"median":-31.238186,"eighty":-12.745675,"marketCap":94879675},{"date":"2022-05-06","current":-9.432168,"twenty":-58.404455,"median":-30.807314,"eighty":-12.573699,"marketCap":91958870},{"date":"2022-05-13","current":-8.943673,"twenty":-57.408729,"median":-30.735502,"eighty":-12.130465,"marketCap":87196282},{"date":"2022-05-20","current":-8.729956,"twenty":-56.928034,"median":-30.591879,"eighty":-11.422833,"marketCap":85112650},{"date":"2022-05-27","current":-8.985653,"twenty":-56.653351,"median":-30.161007,"eighty":-11.246184,"marketCap":87605567},{"date":"2022-06-03","current":-9.302412,"twenty":-56.58468,"median":-29.15564,"eighty":-10.757425,"marketCap":90693807},{"date":"2022-06-10","current":-8.860657,"twenty":-56.481674,"median":-28.437521,"eighty":-10.37032,"marketCap":86386921},{"date":"2022-06-17","current":-8.340685,"twenty":-56.13832,"median":-27.514558,"eighty":-10.217416,"marketCap":81317463},{"date":"2022-06-24","current":-9.028587,"twenty":-55.382942,"median":-26.669522,"eighty":-10.081505,"marketCap":88024154},{"date":"2022-07-01","current":-8.352135,"twenty":-54.284211,"median":-23.884752,"eighty":-9.703863,"marketCap":81429086},{"date":"2022-07-08","current":-9.353942,"twenty":-53.734845,"median":-23.34922,"eighty":-9.444572,"marketCap":91196204},{"date":"2022-07-15","current":-8.87307,"twenty":-52.876461,"median":-22.813687,"eighty":-9.345336,"marketCap":86507939},{"date":"2022-07-22","current":-6.995425,"twenty":-52.533107,"median":-21.528409,"eighty":-9.17838,"marketCap":86477857},{"date":"2022-07-29","current":-6.86721,"twenty":-52.36143,"median":-21.04643,"eighty":-9.063888,"marketCap":84892859},{"date":"2022-08-05","current":-7.414826,"twenty":-51.8464,"median":-20.56445,"eighty":-9.010459,"marketCap":91662518},{"date":"2022-08-12","current":-7.955491,"twenty":-51.674723,"median":-20.136024,"eighty":-8.943673,"marketCap":98346243},{"date":"2022-08-19","current":-7.878253,"twenty":-51.331369,"median":-19.707598,"eighty":-8.934132,"marketCap":97391425},{"date":"2022-08-26","current":-7.204739,"twenty":-51.331369,"median":-17.565468,"eighty":-8.865634,"marketCap":89065413},{"date":"2022-09-02","current":-7.337588,"twenty":-50.644662,"median":-16.708616,"eighty":-8.847309,"marketCap":90707700},{"date":"2022-09-09","current":-8.032728,"twenty":-49.820613,"median":-16.28019,"eighty":-8.8101,"marketCap":99301061},{"date":"2022-09-16","current":-9.125301,"twenty":-45.311835,"median":-15.95887,"eighty":-8.781858,"marketCap":119352237},{"date":"2022-09-23","current":-7.920761,"twenty":-42.742456,"median":-15.530444,"eighty":-8.781858,"marketCap":103597742},{"date":"2022-09-30","current":-8.687286,"twenty":-41.56474,"median":-15.262678,"eighty":-8.69776,"marketCap":113623330},{"date":"2022-10-07","current":-10.147335,"twenty":-41.363667,"median":-14.887805,"eighty":-8.701142,"marketCap":132719688},{"date":"2022-10-14","current":-7.665253,"twenty":-40.214676,"median":-14.834252,"eighty":-8.687286,"marketCap":100255879},{"date":"2022-10-21","current":-8.030265,"twenty":-38.663538,"median":-14.566486,"eighty":-8.680534,"marketCap":105029969},{"date":"2022-10-28","current":-8.249272,"twenty":-38.232667,"median":-13.9774,"eighty":-8.576729,"marketCap":107894422},{"date":"2022-11-04","current":-7.59225,"twenty":-38.089043,"median":-12.852782,"eighty":-8.486801,"marketCap":99301061},{"date":"2022-11-11","current":-7.738255,"twenty":-37.94542,"median":-12.692122,"eighty":-8.408528,"marketCap":101210697},{"date":"2022-11-18","current":-9.214501,"twenty":-37.916695,"median":-12.638569,"eighty":-8.395566,"marketCap":120518905},{"date":"2022-11-25","current":-9.067069,"twenty":-37.830521,"median":-12.317249,"eighty":-8.392247,"marketCap":118590602},{"date":"2022-12-02","current":-8.477341,"twenty":-37.773071,"median":-12.090191,"eighty":-8.401729,"marketCap":110877392},{"date":"2022-12-09","current":-7.816845,"twenty":-37.686897,"median":-11.460397,"eighty":-8.353592,"marketCap":102238597},{"date":"2022-12-16","current":-6.430894,"twenty":-37.543273,"median":-11.367382,"eighty":-8.329909,"marketCap":80960633},{"date":"2022-12-23","current":-4.977892,"twenty":-37.399649,"median":-11.246184,"eighty":-8.295842,"marketCap":62668312},{"date":"2022-12-30","current":-4.326837,"twenty":-37.054951,"median":-11.090129,"eighty":-8.249272,"marketCap":54471964},{"date":"2023-01-06","current":-4.51526,"twenty":-36.423007,"median":-10.804356,"eighty":-8.214363,"marketCap":56844084},{"date":"2023-01-13","current":-4.542068,"twenty":-35.618713,"median":-10.564526,"eighty":-8.17627,"marketCap":57181581},{"date":"2023-01-20","current":-4.472367,"twenty":-35.618713,"median":-10.375203,"eighty":-8.119042,"marketCap":56304089},{"date":"2023-01-27","current":-5.055252,"twenty":-35.475089,"median":-10.282225,"eighty":-8.054457,"marketCap":63642231},{"date":"2023-02-03","current":-5.438226,"twenty":-35.475089,"median":-10.224241,"eighty":-8.030265,"marketCap":68463613},{"date":"2023-02-10","current":-4.673052,"twenty":-34.900594,"median":-10.147335,"eighty":-7.920761,"marketCap":58830589},{"date":"2023-02-17","current":-4.3659,"twenty":-34.75697,"median":-10.073933,"eighty":-7.878253,"marketCap":54963745},{"date":"2023-02-24","current":-3.841226,"twenty":-34.527172,"median":-9.818824,"eighty":-7.811258,"marketCap":48358453},{"date":"2023-03-03","current":-4.289305,"twenty":-34.469722,"median":-9.731754,"eighty":-7.809209,"marketCap":53999469},{"date":"2023-03-10","current":-3.837396,"twenty":-34.354823,"median":-9.703863,"eighty":-7.65286,"marketCap":48310239},{"date":"2023-03-17","current":-2.498119,"twenty":-34.0963,"median":-9.563315,"eighty":-7.541372,"marketCap":38576049},{"date":"2023-03-24","current":-2.747931,"twenty":-34.038851,"median":-9.43837,"eighty":-7.439961,"marketCap":42433654},{"date":"2023-03-31","current":-2.654252,"twenty":-33.923952,"median":-9.353942,"eighty":-7.335734,"marketCap":40987052},{"date":"2023-04-06","current":-3.076062,"twenty":-33.780328,"median":-9.323874,"eighty":-7.312254,"marketCap":47500660},{"date":"2023-04-14","current":-3.641053,"twenty":-33.607979,"median":-9.233457,"eighty":-7.191763,"marketCap":56225271},{"date":"2023-04-21","current":-3.703202,"twenty":-33.36031,"median":-9.202898,"eighty":-6.992181,"marketCap":57184979},{"date":"2023-04-28","current":-3.389318,"twenty":-32.949228,"median":-9.15675,"eighty":-6.88482,"marketCap":52337972},{"date":"2023-05-05","current":-3.20036,"twenty":-32.88986,"median":-9.133043,"eighty":-6.792337,"marketCap":49420075},{"date":"2023-05-12","current":-3.280086,"twenty":-32.88986,"median":-9.106823,"eighty":-6.016057,"marketCap":50651214},{"date":"2023-05-19","current":-3.208521,"twenty":-32.83241,"median":-9.065479,"eighty":-5.207063,"marketCap":49546097},{"date":"2023-05-26","current":-3.70383,"twenty":-32.746236,"median":-9.028587,"eighty":-5.102588,"marketCap":57194673},{"date":"2023-06-02","current":-4.852644,"twenty":-32.717511,"median":-9.019972,"eighty":-4.993364,"marketCap":74934715},{"date":"2023-06-09","current":-4.519928,"twenty":-32.602612,"median":-8.988038,"eighty":-4.818728,"marketCap":69796889},{"date":"2023-06-16","current":-4.26882,"twenty":-32.602612,"median":-8.943673,"eighty":-4.737078,"marketCap":65919284},{"date":"2023-06-23","current":-4.216716,"twenty":-32.602612,"median":-8.934132,"eighty":-4.60028,"marketCap":65114681},{"date":"2023-06-30","current":-3.135072,"twenty":-32.487714,"median":-8.906294,"eighty":-4.555493,"marketCap":48411897},{"date":"2023-07-07","current":-3.089873,"twenty":-32.114291,"median":-8.87307,"eighty":-4.518061,"marketCap":47713929},{"date":"2023-07-14","current":-3.207893,"twenty":-31.884493,"median":-8.86257,"eighty":-4.463788,"marketCap":49536403},{"date":"2023-07-21","current":-3.094895,"twenty":-31.884493,"median":-8.847309,"eighty":-4.404454,"marketCap":47791481},{"date":"2023-07-28","current":-2.949881,"twenty":-31.712144,"median":-8.826942,"eighty":-4.326481,"marketCap":45552164},{"date":"2023-08-04","current":-2.55098,"twenty":-31.597245,"median":-8.811054,"eighty":-4.299147,"marketCap":37953912},{"date":"2023-08-11","current":-2.518929,"twenty":-31.597245,"median":-8.78352,"eighty":-4.26882,"marketCap":37477051},{"date":"2023-08-18","current":-1.824367,"twenty":-31.424897,"median":-8.706103,"eighty":-4.220676,"marketCap":27143234},{"date":"2023-08-25","current":-1.791789,"twenty":-31.309998,"median":-8.693832,"eighty":-4.167979,"marketCap":26658534},{"date":"2023-09-01","current":-1.708389,"twenty":-31.223824,"median":-8.687286,"eighty":-4.122328,"marketCap":25417700},{"date":"2023-09-08","current":-1.758559,"twenty":-31.051475,"median":-8.682251,"eighty":-4.112076,"marketCap":26164139},{"date":"2023-09-15","current":-1.413526,"twenty":-30.850401,"median":-8.632916,"eighty":-4.03519,"marketCap":21724281},{"date":"2023-09-22","current":-1.443802,"twenty":-30.778589,"median":-8.586842,"eighty":-3.869413,"marketCap":22189594},{"date":"2023-09-29","current":-1.504986,"twenty":-30.735502,"median":-8.538778,"eighty":-3.70383,"marketCap":23129913},{"date":"2023-10-06","current":-1.39208,"twenty":-30.735502,"median":-8.491432,"eighty":-3.68462,"marketCap":21394685},{"date":"2023-10-13","current":-1.368742,"twenty":-30.678053,"median":-8.47281,"eighty":-3.559819,"marketCap":21036006},{"date":"2023-10-20","current":-1.281698,"twenty":-30.591879,"median":-8.418917,"eighty":-3.467663,"marketCap":19698233},{"date":"2023-10-27","current":-1.157439,"twenty":-30.591879,"median":-8.410939,"eighty":-3.38982,"marketCap":17788512},{"date":"2023-11-03","current":-0.693833,"twenty":-30.591879,"median":-8.398885,"eighty":-3.331814,"marketCap":10663418},{"date":"2023-11-10","current":-0.593332,"twenty":-30.41953,"median":-8.366706,"eighty":-3.275817,"marketCap":9118838},{"date":"2023-11-17","current":-0.622347,"twenty":-30.132282,"median":-8.340685,"eighty":-3.256733,"marketCap":9564763},{"date":"2023-11-24","current":-0.434255,"twenty":-29.730135,"median":-8.329909,"eighty":-3.228484,"marketCap":6674007},{"date":"2023-12-01","current":-0.508811,"twenty":-29.184365,"median":-8.322274,"eighty":-3.207893,"marketCap":7819840},{"date":"2023-12-08","current":-0.46676,"twenty":-28.782218,"median":-8.256193,"eighty":-3.200862,"marketCap":7173572},{"date":"2023-12-15","current":-0.44153,"twenty":-28.437521,"median":-8.249272,"eighty":-3.173299,"marketCap":6785811},{"date":"2023-12-22","current":-0.422596,"twenty":-28.265172,"median":-8.247184,"eighty":-3.143861,"marketCap":6408632},{"date":"2023-12-29","current":-0.417901,"twenty":-28.006649,"median":-8.200897,"eighty":-3.135072,"marketCap":6337425},{"date":"2024-01-05","current":-0.458799,"twenty":-27.847012,"median":-8.187204,"eighty":-3.104688,"marketCap":6957638},{"date":"2024-01-12","current":-0.436683,"twenty":-27.469353,"median":-8.17627,"eighty":-3.069716,"marketCap":6622253},{"date":"2024-01-19","current":-0.427292,"twenty":-27.212297,"median":-8.147656,"eighty":-3.03149,"marketCap":6479839},{"date":"2024-01-26","current":-0.394087,"twenty":-26.755207,"median":-8.103267,"eighty":-2.950555,"marketCap":5976289},{"date":"2024-02-02","current":-0.379327,"twenty":-26.026883,"median":-8.043592,"eighty":-2.78146,"marketCap":5752450},{"date":"2024-02-09","current":-0.410266,"twenty":-24.977239,"median":-8.032728,"eighty":-2.722825,"marketCap":6221640},{"date":"2024-02-16","current":-0.385301,"twenty":-23.670539,"median":-8.030265,"eighty":-2.666243,"marketCap":5843046},{"date":"2024-02-23","current":-0.384515,"twenty":-23.34922,"median":-7.938126,"eighty":-2.615329,"marketCap":5831132},{"date":"2024-03-01","current":-0.399835,"twenty":-23.284956,"median":-7.88426,"eighty":-2.524663,"marketCap":6063451},{"date":"2024-03-08","current":-0.46264,"twenty":-22.985057,"median":-7.85091,"eighty":-2.242859,"marketCap":7015891},{"date":"2024-03-15","current":-0.423359,"twenty":-22.813687,"median":-7.811258,"eighty":-1.890175,"marketCap":6420203},{"date":"2024-03-22","current":-0.458276,"twenty":-22.749423,"median":-7.811258,"eighty":-1.82567,"marketCap":6949704},{"date":"2024-03-28","current":-0.564774,"twenty":-22.492368,"median":-7.806136,"eighty":-1.823064,"marketCap":7004182},{"date":"2024-04-05","current":-0.49833,"twenty":-21.528409,"median":-7.738255,"eighty":-1.759211,"marketCap":6180161},{"date":"2024-04-12","current":-0.494177,"twenty":-21.314196,"median":-7.597768,"eighty":-1.513816,"marketCap":6128660},{"date":"2024-04-19","current":-0.382607,"twenty":-21.099983,"median":-7.546903,"eighty":-1.494894,"marketCap":4744990},{"date":"2024-04-26","current":-0.38759,"twenty":-20.992877,"median":-7.495539,"eighty":-1.443802,"marketCap":4806792},{"date":"2024-05-03","current":-0.406969,"twenty":-20.778664,"median":-7.414826,"eighty":-1.422987,"marketCap":5047131},{"date":"2024-05-10","current":-0.326683,"twenty":-20.56445,"median":-7.340087,"eighty":-1.386403,"marketCap":4051439},{"date":"2024-05-17","current":-0.360039,"twenty":-20.350237,"median":-7.327547,"eighty":-1.331528,"marketCap":4465116},{"date":"2024-05-24","current":-0.329749,"twenty":-20.350237,"median":-7.245289,"eighty":-1.311974,"marketCap":4089461},{"date":"2024-05-31","current":-0.350903,"twenty":-20.007496,"median":-7.193926,"eighty":-1.267695,"marketCap":4351810},{"date":"2024-06-07","current":-0.344956,"twenty":-19.750441,"median":-7.067256,"eighty":-1.032675,"marketCap":4278051},{"date":"2024-06-14","current":-0.270314,"twenty":-19.707598,"median":-6.985384,"eighty":-0.73363,"marketCap":3352369},{"date":"2024-06-21","current":-0.249795,"twenty":-19.386279,"median":-6.922821,"eighty":-0.678695,"marketCap":3097899},{"date":"2024-06-28","current":-0.23457,"twenty":-18.336635,"median":-6.85099,"eighty":-0.605695,"marketCap":2909074},{"date":"2024-07-05","current":-0.232488,"twenty":-17.608311,"median":-6.83991,"eighty":-0.576932,"marketCap":2883259},{"date":"2024-07-12","current":-0.265612,"twenty":-17.351255,"median":-6.404852,"eighty":-0.543277,"marketCap":3294056},{"date":"2024-07-19","current":-0.239418,"twenty":-17.094199,"median":-5.859497,"eighty":-0.509547,"marketCap":2969207},{"date":"2024-07-26","current":-0.245211,"twenty":-16.580088,"median":-5.270484,"eighty":-0.495838,"marketCap":3041043},{"date":"2024-08-02","current":-0.275684,"twenty":-16.344454,"median":-5.200016,"eighty":-0.489306,"marketCap":2742439},{"date":"2024-08-09","current":-0.180548,"twenty":-16.237347,"median":-5.107337,"eighty":-0.487256,"marketCap":1796045},{"date":"2024-08-16","current":-0.172506,"twenty":-16.173083,"median":-5.055252,"eighty":-0.469552,"marketCap":1716043},{"date":"2024-08-23","current":-0.260463,"twenty":-16.001713,"median":-4.885013,"eighty":-0.465618,"marketCap":2591016},{"date":"2024-08-30","current":-0.19873,"twenty":-15.701815,"median":-4.815511,"eighty":-0.461152,"marketCap":1976911},{"date":"2024-09-06","current":-0.179279,"twenty":-15.61613,"median":-4.742746,"eighty":-0.458291,"marketCap":1783426},{"date":"2024-09-13","current":-1.01534,"twenty":-15.509023,"median":-4.725895,"eighty":-0.458276,"marketCap":7507818},{"date":"2024-09-20","current":-0.88908,"twenty":-15.401917,"median":-4.60028,"eighty":-0.458291,"marketCap":6574203},{"date":"2024-09-27","current":-0.931166,"twenty":-15.29481,"median":-4.568075,"eighty":-0.45844,"marketCap":6885408},{"date":"2024-10-04","current":-1.004693,"twenty":-15.166282,"median":-4.527515,"eighty":-0.459071,"marketCap":7429094},{"date":"2024-10-11","current":-1.004693,"twenty":-14.973491,"median":-4.504919,"eighty":-0.460656,"marketCap":7429094},{"date":"2024-10-18","current":-1.013772,"twenty":-14.887805,"median":-4.472367,"eighty":-0.46264,"marketCap":7496225},{"date":"2024-10-25","current":-0.974431,"twenty":-14.887805,"median":-4.442112,"eighty":-0.462971,"marketCap":7205326},{"date":"2024-11-01","current":-0.995615,"twenty":-14.866384,"median":-4.3659,"eighty":-0.464406,"marketCap":7361964},{"date":"2024-11-08","current":-0.901803,"twenty":-14.780699,"median":-4.340624,"eighty":-0.465237,"marketCap":6668283},{"date":"2024-11-15","current":-0.823122,"twenty":-14.737856,"median":-4.320297,"eighty":-0.466809,"marketCap":6086487},{"date":"2024-11-22","current":-0.79286,"twenty":-14.523643,"median":-4.299038,"eighty":-0.467514,"marketCap":5862719},{"date":"2024-11-29","current":-0.786808,"twenty":-14.352273,"median":-4.289305,"eighty":-0.469552,"marketCap":5817965},{"date":"2024-12-06","current":-0.68997,"twenty":-14.245166,"median":-4.26882,"eighty":-0.469552,"marketCap":5101908},{"date":"2024-12-13","current":-1.105148,"twenty":-13.709634,"median":-4.224965,"eighty":-0.470645,"marketCap":6465027},{"date":"2024-12-20","current":-1.030852,"twenty":-13.281208,"median":-4.217971,"eighty":-0.470965,"marketCap":6030403},{"date":"2024-12-27","current":-1.114435,"twenty":-12.938467,"median":-4.174413,"eighty":-0.483998,"marketCap":6519355},{"date":"2025-01-03","current":-1.170156,"twenty":-12.788518,"median":-4.153732,"eighty":-0.487256,"marketCap":6845323},{"date":"2025-01-10","current":-1.049426,"twenty":-12.745675,"median":-4.125392,"eighty":-0.487256,"marketCap":6139060},{"date":"2025-01-17","current":-1.077287,"twenty":-12.702833,"median":-4.112754,"eighty":-0.487884,"marketCap":6302043},{"date":"2025-01-24","current":-1.086574,"twenty":-12.638569,"median":-4.102462,"eighty":-0.488827,"marketCap":6356371},{"date":"2025-01-31","current":-1.05407,"twenty":-12.638569,"median":-4.059521,"eighty":-0.489066,"marketCap":6166224},{"date":"2025-02-07","current":-1.058713,"twenty":-12.606134,"median":-4.000803,"eighty":-0.490035,"marketCap":6193388},{"date":"2025-02-14","current":-1.012278,"twenty":-12.444566,"median":-3.841226,"eighty":-0.490462,"marketCap":5921747},{"date":"2025-02-21","current":-0.889319,"twenty":-12.317249,"median":-3.766606,"eighty":-0.491991,"marketCap":5202445},{"date":"2025-02-28","current":-0.924791,"twenty":-12.317249,"median":-3.703516,"eighty":-0.494177,"marketCap":5409953},{"date":"2025-03-07","current":-0.857123,"twenty":-12.29156,"median":-3.68688,"eighty":-0.49471,"marketCap":5014103},{"date":"2025-03-14","current":-1.05699,"twenty":-11.888823,"median":-3.6588,"eighty":-0.49833,"marketCap":4467829},{"date":"2025-03-21","current":-1.576432,"twenty":-11.737053,"median":-3.547515,"eighty":-0.503313,"marketCap":6663479},{"date":"2025-03-28","current":-1.654473,"twenty":-11.460397,"median":-3.517069,"eighty":-0.505711,"marketCap":6993354},{"date":"2025-04-04","current":-1.533822,"twenty":-11.4598,"median":-3.389946,"eighty":-0.508811,"marketCap":6483367},{"date":"2025-04-11","current":-1.197464,"twenty":-11.367382,"median":-3.343805,"eighty":-0.51065,"marketCap":5061605},{"date":"2025-04-17","current":-1.045752,"twenty":-11.367382,"median":-3.311475,"eighty":-0.514141,"marketCap":4420327},{"date":"2025-04-25","current":-1.06136,"twenty":-11.293448,"median":-3.280086,"eighty":-0.521998,"marketCap":4486302},{"date":"2025-05-02","current":-1.045752,"twenty":-11.25194,"median":-3.263764,"eighty":-0.535975,"marketCap":4420327},{"date":"2025-05-09","current":-1.027178,"twenty":-11.246184,"median":-3.24807,"eighty":-0.547521,"marketCap":4341817},{"date":"2025-05-16","current":-0.589644,"twenty":-11.12134,"median":-3.229551,"eighty":-0.552889,"marketCap":2492390},{"date":"2025-05-23","current":-0.617392,"twenty":-10.868327,"median":-3.208521,"eighty":-0.562559,"marketCap":2609679},{"date":"2025-05-30","current":-0.943431,"twenty":-10.807764,"median":-3.207893,"eighty":-0.56825,"marketCap":3987824},{"date":"2025-06-06","current":-0.64514,"twenty":-10.754017,"median":-3.201615,"eighty":-0.571359,"marketCap":2726968},{"date":"2025-06-13","current":-0.553225,"twenty":-10.699691,"median":-3.194082,"eighty":-0.571359,"marketCap":2338448},{"date":"2025-06-20","current":-0.523743,"twenty":-10.58879,"median":-3.176505,"eighty":-0.556978,"marketCap":2213829},{"date":"2025-06-27","current":-0.5064,"twenty":-10.425771,"median":-3.160811,"eighty":-0.537143,"marketCap":2140523},{"date":"2025-07-03","current":-0.509869,"twenty":-10.389853,"median":-3.144175,"eighty":-0.523743,"marketCap":2155184},{"date":"2025-07-11","current":-0.529834,"twenty":-10.339297,"median":-3.135072,"eighty":-0.515026,"marketCap":2239575},{"date":"2025-07-18","current":-0.648049,"twenty":-10.291116,"median":-3.103056,"eighty":-0.516806,"marketCap":2739262},{"date":"2025-07-25","current":-1.918187,"twenty":-10.277454,"median":-3.085135,"eighty":-0.523743,"marketCap":8660331},{"date":"2025-07-30","current":-1.667989,"twenty":-10.26314,"median":-3.068129,"eighty":-0.523744,"marketCap":7530723}],"updateTime":1754010942453}}}